Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2013-04-05 | Mr. Bradbury served as Chief Executive Officer of Amylin Pharmaceuticals, Inc., a biopharmaceutical company focused on diabetes and metabolic disorders... He received a Bachelor of Pharmacy from Nottingham University and a Diploma in Management Studies. |
| 2014-04-04 | Mr. Bradbury received a Bachelor of Pharmacy from Nottingham University and a Diploma in Management Studies from Harrow and Ealing Colleges of Higher Education in the United Kingdom. |
| 2015-04-03 | Mr. Bradbury served as Chief Executive Officer of Amylin Pharmaceuticals, Inc., a biopharmaceutical company focused on diabetes and metabolic disorders. |
| 2016-04-01 | He received a Bachelor of Pharmacy from Nottingham University and a Diploma in Management Studies from Harrow and Ealing Colleges of Higher Education in the United Kingdom. |
| 2017-03-24 | Mr. Bradbury has served as a director of Geron since September 2012. He also serves as a director for Illumina, Inc., a manufacturer of life science tools and reagents, since January 2004; Corcept Therapeutics Incorporated, a company focused on the discovery and development of drugs; and Intercept Pharmaceuticals, Inc., a biopharmaceutical company. |
| 2018-03-30 | He received a Bachelor of Pharmacy from Nottingham University and a Diploma in Management Studies from Harrow and Ealing Colleges of Higher Education in the United Kingdom. |
| 2019-04-22 | Mr. Bradbury held several senior positions at Amylin Pharmaceuticals and has a Bachelor of Pharmacy and a Diploma in Management Studies. |
Data sourced from SEC filings. Last updated: 2025-10-11